StonvexLoading…
StonvexCore line items from EXPE's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $14.73B | $13.69B | $12.84B | $11.67B |
Operating Income | $1.87B | $1.32B | $1.03B | $1.08B |
Net Income | $1.29B | $1.23B | $797.00M | $352.00M |
EPS (Diluted) | $9.81 | $8.95 | $5.31 | $2.17 |
Total Assets | $24.45B | $22.39B | $21.64B | $21.56B |
Total Liabilities | Not available | Not available | Not available | Not available |
Cash & Equivalents | $5.41B | $4.18B | $4.22B | $4.10B |
Free Cash Flow OCF − CapEx | $3.11B | $2.33B | $1.84B | $2.78B |
Shares Outstanding | 116.97M | 123.27M | 131.52M | 147.76M |